Drug-resistance of non-fermentative bacteria and clinical strategy

ZHOU Yun-Fang

Journal of Microbes and Infections ›› 2013, Vol. 8 ›› Issue (3) : 133-137.

PDF(634 KB)
Welcome to visit Journal of Microbes and Infections, March 14, 2025
PDF(634 KB)
Journal of Microbes and Infections ›› 2013, Vol. 8 ›› Issue (3) : 133-137.
Invited paper

Drug-resistance of non-fermentative bacteria and clinical strategy

  • ZHOU Yun-Fang
Author information +
History +

Abstract

Non-fermentative bacteria can exist extensively in the environment. The use of antibiotics and cross-infection by the hands of medical personnel have made it become the major pathogen of nosocomial infection. The intrinsic resistance to many common antibiotics in non-fermentative bacteria, and antibiotic pressure have caused the rapid increase in multi-resistance rate. The resistance rate of Acinetobacter baumanii to carbapanems has risen to more than 50%. Some pathogens are resistant to disinfectors. Non-fermentative bacteria are primarily opportunistic pathogens. Underlying host factors are strongly associated with outcomes. Multidrug resistance greatly limits the therapeutic options for patients who are infected with this organism. Carbapenems is still a class of optional antibiotics, as well as polymyxin, tigecycline, sulbactam and its compounds. How to manage the patients with non-fermentative bacteria infection will be a challenge for clinicians in the future.

Key words

Non-fermentative bacterium / Drug resistance rate / Antibiotic

Cite this article

Download Citations
ZHOU Yun-Fang. Drug-resistance of non-fermentative bacteria and clinical strategy[J]. Journal of Microbes and Infections. 2013, 8(3): 133-137
PDF(634 KB)

41

Accesses

0

Citation

Detail

Sections
Recommended

/